Drug Pipeline

Dendritic Cell Vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
1
Recruiting
4
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-08 NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03384914 Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer Breast Cancer Female Active, Not Recruiting
NCT06805656 Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV… Hiv Not Yet Recruiting
NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and… Ovarian Cancer Not Yet Recruiting
Phase 1
NCT05809752 A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) Leptomeningeal Disease Active, Not Recruiting
Not specified
NCT06682117 A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of… Treatment Recruiting
Sponsors Running Dendritic Cell Vaccine Trials
H. Lee Moffitt Cancer Center and Research Institute (2) Fudan University (1) Federal University of São Paulo (1) Kalinski, Pawel, MD, PhD (1)
Disease Areas
Breast Cancer (2) HER2-Positive Breast Cancer (2) Triple-Negative Breast Cancer (1) Ovarian Cancer (1)
Get alerts when Dendritic Cell Vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free